OBJECTIVE: Heterocyclic amines (HAA) are animal carcinogens that are present in meat cooked at high temperature and in tobacco smoke. These compounds require activation by cytochrome P450 1A2 (CYP1A2) and N-acetyltransferase-2 (NAT2) before they can damage DNA. This study tested the hypotheses that well-done meat and cigarette smoking increase the risk of adenoma, the precursor to most colorectal cancers, especially in individuals with rapid CYP1A2 and rapid NAT2 activities. DESIGN: An endoscopy-based case-control study of adenoma was conducted among Caucasians, Japanese and native Hawaiians to test this hypothesis. The overall diet and consumption of well-done meat cooked by various high-temperature methods were assessed by interview in 1016 patients with a first adenoma and 1355 controls with a normal endoscopy. A caffeine test was used to assess CYP1A2 and NAT2 activities in 635 cases and 845 controls. Logistic regression was used to account for matching factors and potential confounders. RESULTS: Smoking was associated with an increased risk of adenoma. Weak non-significant elevated OR were observed for the main effects of HAA intakes or NAT2 activity. However, the combined effects of HAA intakes and NAT2 activity were statistically significant. Subjects in both the upper tertiles of NAT2 activity and HAA intake were at increased risk of adenoma compared with subjects in the lower tertiles of NAT2 activity and exposure (2-amino-3,4,8-dimethylimidazo[4,5-f]quinoxaline intake OR 1.70, 95% CI I 1.06 to 2.75; 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline intake OR 1.91, 95% CI 1.16 to 3.16; and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine intake OR 2.14, 95% CI 1.31 to 3.49). CONCLUSION: The data suggest that rapid N-acetylators with high HAA intake may be at increased risk of adenoma.
OBJECTIVE:Heterocyclic amines (HAA) are animal carcinogens that are present in meat cooked at high temperature and in tobacco smoke. These compounds require activation by cytochrome P450 1A2 (CYP1A2) and N-acetyltransferase-2 (NAT2) before they can damage DNA. This study tested the hypotheses that well-done meat and cigarette smoking increase the risk of adenoma, the precursor to most colorectal cancers, especially in individuals with rapid CYP1A2 and rapid NAT2 activities. DESIGN: An endoscopy-based case-control study of adenoma was conducted among Caucasians, Japanese and native Hawaiians to test this hypothesis. The overall diet and consumption of well-done meat cooked by various high-temperature methods were assessed by interview in 1016 patients with a first adenoma and 1355 controls with a normal endoscopy. A caffeine test was used to assess CYP1A2 and NAT2 activities in 635 cases and 845 controls. Logistic regression was used to account for matching factors and potential confounders. RESULTS: Smoking was associated with an increased risk of adenoma. Weak non-significant elevated OR were observed for the main effects of HAA intakes or NAT2 activity. However, the combined effects of HAA intakes and NAT2 activity were statistically significant. Subjects in both the upper tertiles of NAT2 activity and HAA intake were at increased risk of adenoma compared with subjects in the lower tertiles of NAT2 activity and exposure (2-amino-3,4,8-dimethylimidazo[4,5-f]quinoxaline intake OR 1.70, 95% CI I 1.06 to 2.75; 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline intake OR 1.91, 95% CI 1.16 to 3.16; and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine intake OR 2.14, 95% CI 1.31 to 3.49). CONCLUSION: The data suggest that rapid N-acetylators with high HAA intake may be at increased risk of adenoma.
Authors: Jun Wang; Amit D Joshi; Román Corral; Kimberly D Siegmund; Loïc Le Marchand; Maria Elena Martinez; Robert W Haile; Dennis J Ahnen; Robert S Sandler; Peter Lance; Mariana C Stern Journal: Int J Cancer Date: 2011-08-08 Impact factor: 7.396
Authors: Hansong Wang; Jennifer F Yamamoto; Christian Caberto; Barbara Saltzman; Robert Decker; Thomas M Vogt; Lance Yokochi; Stephen Chanock; Lynne R Wilkens; Loïc Le Marchand Journal: Carcinogenesis Date: 2010-11-16 Impact factor: 4.944
Authors: Naoko Ishibe; Rashmi Sinha; David W Hein; Martin Kulldorff; Paul Strickland; Adrian J Fretland; Wong-Ho Chow; Fred F Kadlubar; Nicholas P Lang; Nathaniel Rothman Journal: Pharmacogenetics Date: 2002-03
Authors: Michelle Cotterchio; Beatrice A Boucher; Michael Manno; Steven Gallinger; Allan B Okey; Patricia A Harper Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-11 Impact factor: 4.254
Authors: Leah M Ferrucci; Rashmi Sinha; Barry I Graubard; Susan T Mayne; Xiaomei Ma; Arthur Schatzkin; Philip S Schoenfeld; Brooks D Cash; Andrew Flood; Amanda J Cross Journal: Am J Gastroenterol Date: 2009-04-14 Impact factor: 10.864
Authors: Ute Nöthlings; Jennifer F Yamamoto; Lynne R Wilkens; Suzanne P Murphy; Song-Yi Park; Brian E Henderson; Laurence N Kolonel; Loïc Le Marchand Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-06-23 Impact factor: 4.254
Authors: Mona Saebø; Camilla F Skjelbred; Karin Brekke Li; Inger Marie Bowitz Lothe; Per Chr Hagen; Egil Johnsen; Kjell M Tveit; Elin H Kure Journal: Anticancer Res Date: 2008 Jul-Aug Impact factor: 2.480
Authors: Gary Ginsberg; Suryanarayana V Vulimiri; Yu-Sheng Lin; Jayaram Kancherla; Brenda Foos; Babasaheb Sonawane Journal: J Toxicol Environ Health A Date: 2017-09-11
Authors: Melissa Kang; Anne F Peery; Cameron Locklear; Joseph A Galanko; Robert S Sandler; Temitope O Keku Journal: J Gastroenterol Hepatol Res Date: 2013-04-14
Authors: Hansong Wang; Motoki Iwasaki; Christopher A Haiman; Suminori Kono; Lynne R Wilkens; Temitope O Keku; Sonja I Berndt; Shoichiro Tsugane; Loïc Le Marchand Journal: PLoS One Date: 2015-12-18 Impact factor: 3.240
Authors: Maximilian Mimmler; Simon Peter; Alexander Kraus; Svenja Stroh; Teodora Nikolova; Nina Seiwert; Solveig Hasselwander; Carina Neitzel; Jessica Haub; Bernhard H Monien; Petra Nicken; Pablo Steinberg; Jerry W Shay; Bernd Kaina; Jörg Fahrer Journal: Nucleic Acids Res Date: 2016-09-05 Impact factor: 16.971